MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells (original) (raw)
Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D et al. (2005). Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med353: 2243–2253. ArticleCASPubMed Google Scholar
Brodeur GM . (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer3: 203–216. ArticleCASPubMed Google Scholar
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM . (1984). Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science224: 1121–1124. ArticleCASPubMed Google Scholar
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA99: 15524–15529. ArticleCASPubMed Google Scholar
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med353: 1793–1801. ArticleCASPubMed Google Scholar
Chan JA, Krichevsky AM, Kosik KS . (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res65: 6029–6033. ArticleCASPubMed Google Scholar
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res33: e179. ArticlePubMedPubMed Central Google Scholar
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA102: 13944–13949. ArticleCASPubMed Google Scholar
Ejeskar K, Krona C, Caren H, Zaibak F, Li L, Martinsson T et al. (2005). Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer5: 161. ArticlePubMedPubMed Central Google Scholar
Esquela-Kerscher A, Slack FJ . (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer6: 259–269. ArticleCASPubMed Google Scholar
Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE et al. (1989). Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA86: 3753–3757. ArticleCASPubMed Google Scholar
Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T et al. (2006). Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene384: 51–61. ArticleCASPubMed Google Scholar
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature435: 828–833. ArticleCASPubMedPubMed Central Google Scholar
Janoueix-Lerosey I, Novikov E, Monteiro M, Gruel N, Schleiermacher G, Loriod B et al. (2004). Gene expression profiling of 1p35-36 genes in neuroblastoma. Oncogene23: 5912–5922. ArticleCASPubMed Google Scholar
Johnson DG, Degregori J . (2006). Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr Mol Med6: 731–738. CASPubMed Google Scholar
Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, Huang GT et al. (1999). Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer35: 1730–1734. ArticleCASPubMed Google Scholar
Miska EA . (2005). How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev15: 563–568. ArticleCASPubMed Google Scholar
Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D et al. (2005). High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer43: 390–403. ArticleCASPubMed Google Scholar
O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature435: 839–843. ArticleCASPubMed Google Scholar
Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM et al. (1994). Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer10: 275–281. ArticleCASPubMed Google Scholar
Spitz R, Hero B, Ernestus K, Berthold F . (2003). Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4 s neuroblastoma. Clin Cancer Res9: 52–58. CASPubMed Google Scholar
Stallings RL, Nair P, Maris JM, Catchpoole D, McDermott M, O'Meara A et al. (2006). High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res66: 3673–3680. ArticleCASPubMed Google Scholar
Thiele CJ, Reynolds CP, Israel MA . (1985). Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature313: 404–406. ArticleCASPubMed Google Scholar
Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R . (2005). Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res65: 3136–3145. ArticleCASPubMed Google Scholar
Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R et al. (1994). 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer10: 103–114. ArticleCASPubMed Google Scholar
Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N et al. (2005). Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol23: 2280–2299. ArticleCASPubMed Google Scholar
Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D et al. (2006). Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res66: 6050–6062. ArticleCASPubMed Google Scholar